The Fly
Mon, March 30, 2026 astatine 8:41 AM CDT 3 min read
The astir talked astir and marketplace moving probe calls astir Wall Street are present successful 1 place. Here are today's probe calls that investors request to know, arsenic compiled by The Fly.
Top 5 Upgrades:
-
Jefferies upgraded Instacart (CART) to Buy from Hold with a terms people of $45, up from $38. The institution is positioned to bushed statement estimates, trades astatine "notable growth-adjusted" discount, and is little exposed to geopolitical risks, contends the firm.
-
Wolfe Research upgraded CrowdStrike (CRWD) to Outperform from Peer Perform with a $450 terms target. The steadfast says Anthropic's upcoming exemplary merchandise "has the imaginable to ignite a instrumentality velocity cyberwar the likes of which we person ne'er seen."
-
Jefferies upgraded Expedia (EXPE) to Buy from Hold with a terms people of $300, up from $240. The steadfast sees a buying accidental successful Expedia pursuing the pullback.
-
Arete upgraded Analog Devices (ADI) to Buy from Neutral with a $389 terms target. The steadfast says the company's "structural" businesses tin thrust 71% of incremental maturation this rhythm to $19.3B of income successful fiscal 2028, supra the statement estimation of $16.7B.
-
HSBC upgraded Carnival (CCL) to Buy from Hold with a terms people of $30.10, down from $33.60. The company's Q4 study shows "continued resilient" demand, improving operating discipline, and the affirmative interaction of deleveraging, the steadfast tells investors successful a probe note.
Top 5 Downgrades:
-
Raymond James downgraded Boston Scientific (BSX) to Outperform from Strong Buy with a terms people of $88, down from $97. The steadfast reduced estimates beneath statement to bespeak slower trends successful Boston Scientific's "key maturation areas."
-
Keefe Bruyette downgraded Hartford Financial (HIG) to Market Perform from Outperform with a terms people of $149, down from $163. The steadfast cites concerns astir Hartford liability reserve adequacy for the downgrade.
-
Citi downgraded Ovintiv (OVV) to Neutral from Buy with a terms people of $62, up from $52. The steadfast says the company's escaped currency travel is worse than peers fixed its little leverage to higher lipid prices.
-
Jefferies downgraded PTC Therapeutics (PTCT) to Hold from Buy with a terms people of $76, down from $91, pursuing a transportation successful expert coverage. The communicative has shifted to the Sephience launch, but the steadfast awaits advancement to ascribe much worth for further indications.
-
Barclays downgraded Terns Pharmaceuticals (TERN) to Equal Weight from Overweight with a $53 terms target, down from $56, aft the institution agreed to beryllium acquired by Merck (MRK) for $53 per share.

4 days ago
3



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·